Summary
- Current Price
- As of today, PLYX price is $2.52, down -30.01% in the most recent trading session on
- Current Price All-Time High
- PLYX price is currently -94.85% below its historical high of $48.91 set on
- Market Cap
- PLYX current market cap is $119M, with unknown 1-year change
- PE Ratio
- PLYX PE ratio is unknown
- Revenue
- PLYX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for PLYX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Polaryx Therapeutics, Inc. |
| Ticker | NASDAQ: PLYX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | polaryx.com |
| Employees | 2 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.52 | ||
| Price, 1D Change | -30.01% | |
| $119M | ||
| - | ||
| - | ||
| 0.81 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.19 | ||
| EPS, 1Y Change | +70.40% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.19 | ||
| EPS Estimate | N/A | -$0.12 |
| EPS Est. Change | N/A | +36.78% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.52 | ||
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +296.89% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.19 | -$0.19 | +0.11% | |
| -$0.12 | N/A | +36.78% | |
| -$0.28 | N/A | -47.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| +70.40% | ||
| -137.84% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $2.52 | ||
| $5.72 | ||
| SMA 200 vs Price | +126.82% | |
| $5.24 | ||
| SMA 50 vs Price | +107.88% | |
| 0.81 | ||
| $0.68 | ||
| 42.30 | ||
| 177.95% | ||
| 280.98% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.19 | ||
| $0.00 | ||
| - | ||
| -$7.82M | ||
| - | ||
| -$8.99M | ||
| - | ||
| -$7.82M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 8.55 | ||
| 8.55 | ||
| - | ||
| - | ||
| 54.22 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 47.95 | ||
| -24.58 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $4.56M | ||
| $5.14M | ||
| $5.42M | ||
| $5.17M | ||
| $855.00K | ||
| $605.00K | ||
| $0.00 | ||
| $0.00 | ||
| $470.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $8.99M | ||
| $7.82M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$3.94M | ||
| $0.00 | ||
| $4.47M | ||
| $0.00 | ||
| -$3.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group |
Analyst sentiment
Institutional ownership
Screeners with PLYX
FAQ
What is the ticker symbol for Polaryx Therapeutics, Inc.?
The ticker symbol for Polaryx Therapeutics, Inc. is NASDAQ:PLYX
Does Polaryx Therapeutics, Inc. pay dividends?
No, Polaryx Therapeutics, Inc. does not pay dividends
What sector is Polaryx Therapeutics, Inc. in?
Polaryx Therapeutics, Inc. is in the Healthcare sector
What industry is Polaryx Therapeutics, Inc. in?
Polaryx Therapeutics, Inc. is in the Biotechnology industry
What country is Polaryx Therapeutics, Inc. based in?
Polaryx Therapeutics, Inc. is headquartered in United States
When did Polaryx Therapeutics, Inc. go public?
Polaryx Therapeutics, Inc. initial public offering (IPO) was on February 2, 2026
Is Polaryx Therapeutics, Inc. in the S&P 500?
No, Polaryx Therapeutics, Inc. is not included in the S&P 500 index
Is Polaryx Therapeutics, Inc. in the NASDAQ 100?
No, Polaryx Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Polaryx Therapeutics, Inc. in the Dow Jones?
No, Polaryx Therapeutics, Inc. is not included in the Dow Jones index
When does Polaryx Therapeutics, Inc. report earnings?
The next expected earnings date for Polaryx Therapeutics, Inc. is May 29, 2026
Data Sources & References
- PLYX Official Website polaryx.com
- PLYX Profile on Yahoo Finance finance.yahoo.com/quote/PLYX
- PLYX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/plyx